All Articles

The FDA creates a quicker path for gene therapies

Published: 20260223T220000Z

The FDA creates a quicker path for gene therapies

The Food and Drug Administration aims to evaluate treatments for rare diseases based on plausible evidence that they would work — without requiring a clinical trial first.

FDA Launches Framework for Accelerating Development of Individualized Therapies for Ultra - Rare Diseases

Published: 20260223T194500Z

FDA moves to facilitate personalized therapies for rare diseases

Published: 20260223T194500Z

FDA proposes new treatment approval pathway for ultra-rare diseases

The Food and Drug Administration (FDA) on Monday announced a new proposal for flexible drug approval pathway treatments addressing ultra-rare diseases. The FDA unveiled draft guidance on a proposed regulatory pathway for individualized therapies, treatments for rare conditions that affect a very small population, with the proposal specifically focusing on genome editing and RNA-based therapies....

STAT+: FDA unveils rules for bespoke gene therapies, predicting flood of rare disease applications

The FDA expects a flood of applications for a new "plausible mechanism pathway" for approval of bespoke gene-editing treatments.

First-of-a-kind stem cell therapies set for approval in Japan

Scientists reveal how exercise protects the brain from Alzheimer’s

Exercise may sharpen the mind by repairing the brain’s protective shield. Researchers found that physical activity prompts the liver to release an enzyme that removes a harmful protein causing the blood-brain barrier to become leaky with age. In older mice, dialing down this protein reduced inflammation and improved memory. The discovery points to a surprising body-to-brain pathway that could inspire new Alzheimer’s therapies.

Alternative Therapies That Are Changing How People Age

Published: 20260220T010000Z

Paediatricians’ blood used to make new treatments for RSV and colds

Antibodies harvested from the blood of paediatricians are up to 25 times better at protecting against the common respiratory infection RSV than existing antibody therapies, and are now being developed as preventative treatments

STAT+: Biotech startup raises $175 million to advance Alzheimer’s antibody therapy

Is there room for more Alzheimer’s antibody therapies on the market? Korsana Biosciences' investors think so.

Researchers Expand Potential Of Virus For New Cancer Therapies And Next - generation Vaccines

Published: 20260218T101500Z

Therabody JetBoots Pro Plus Review: 3-in-1 Recovery Tech

The JetBoots Pro Plus promise faster, more effective recovery by combining multiple therapies in one device. I tested whether it’s worth the $1,150 splurge.